Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
91,2 USD | -0,93% | +0,81% | -5,41% |
24/04 | Transcript : BioMarin Pharmaceutical Inc., Q1 2024 Earnings Call, Apr 24, 2024 | |
24/04 | BioMarin Pharmaceutical Q1 Non-GAAP EPS, omzetstijging -- Aandelen na uur omlaag | MT |
Vakgebied
Aantal werknemers: 3 401
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Innovative Therapies
100,0
%
| 2 096 | 100,0 % | 2 419 | 100,0 % | +15,42% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
31,9
%
| 684 | 32,6 % | 771 | 31,9 % | +12,72% |
Europe
27,7
%
| 651 | 31,1 % | 669 | 27,7 % | +2,82% |
Rest of World
19,4
%
| 312 | 14,9 % | 468 | 19,4 % | +50,28% |
Latin America
13,7
%
| 267 | 12,7 % | 332 | 13,7 % | +24,60% |
Global
7,4
%
| 182 | 8,7 % | 178 | 7,4 % | -2,47% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alexander Hardy
CEO | Chief Executive Officer | 56 | 01/12 |
Brian Mueller
DFI | Director of Finance/CFO | 50 | 01-12-02 |
Kevin Eggan
CTO | Chief Tech/Sci/R&D Officer | - | 05-10-20 |
Philip Lo Scalzo
CMP | Compliance Officer | - | 01-01-07 |
Chief Tech/Sci/R&D Officer | - | 01-11-08 | |
C. Guyer
CTO | Chief Tech/Sci/R&D Officer | 62 | - |
Stuart Bunting
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-08 |
Henry Fuchs
CTO | Chief Tech/Sci/R&D Officer | 66 | 01-03-09 |
Director/Board Member | 70 | 16-05-05 | |
Traci McCarty
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 04-01-16 |
Director/Board Member | 70 | 16-05-05 | |
Randy Meier
CHM | Chairman | 65 | 14-12-06 |
Elaine Heron
BRD | Director/Board Member | 76 | 01-07-02 |
V. Lawlis
BRD | Director/Board Member | 72 | 01-06-07 |
May Kin Ho
BRD | Director/Board Member | 71 | 17-02-21 |
Mark Enyedy
BRD | Director/Board Member | 60 | 27/12 |
Robert Hombach
BRD | Director/Board Member | 58 | 29-09-17 |
Willard Dere
BRD | Director/Board Member | 70 | 18-07-16 |
Director/Board Member | 66 | 10-07-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 189 775 040 | 188 177 949 ( 99,16 %) | 0 | 99,16 % |
Bedrijfsgegevens
BioMarin Pharmaceutical, Inc.
770 Lindaro Street
94901, San Rafael
+415 506 6700
http://www.biomarin.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
BioMarin International Ltd.
BioMarin International Ltd. BiotechnologyHealth Technology BioMarin International develops and commercializes biopharmaceuticals. The company was founded on June 16, 2011 and is headquartered in Dublin, Ireland. |
Biotechnology
|
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,41% | 17,31 mld. | |
-2,86% | 87,31 mld. | |
+3,95% | 40,86 mld. | |
-21,94% | 29,36 mld. | |
+56,34% | 24,49 mld. | |
-17,60% | 11,62 mld. | |
-13,96% | 11,31 mld. | |
-44,23% | 11,26 mld. | |
+6,37% | 8,31 mld. | |
-9,82% | 7,9 mld. |
- Beurs
- Aandelen
- Koers BMRN
- Onderneming BioMarin Pharmaceutical Inc.